A tailored course, built for your situation
Compliance-Ready AI in Pharmaceutical R&D Operations
Implementation-grade mastery for regulated innovation at scale
The situation this course is for
AI pilots stall in pharma R&D due to misalignment between data science ambitions and compliance requirements. Teams face rework, delayed approvals, and audit findings because systems lack traceability, validation, or documentation built for regulated environments.
Who this is for
Business and technology professionals in established pharmaceutical enterprises leading or supporting AI adoption in R&D, regulatory affairs, quality assurance, or digital transformation roles.
Who this is not for
Startups without established compliance frameworks, non-pharma industries, or individuals seeking theoretical AI overviews.
What you walk away with
- Apply AI governance frameworks aligned with FDA and EMA expectations
- Design model development pipelines that meet GxP and ALCOA+ standards
- Produce audit-ready documentation for AI-driven R&D processes
- Lead cross-functional initiatives balancing innovation velocity with compliance rigor
- Deploy validated AI models in clinical development and drug discovery workflows
The 12 modules (with all 144 chapters)
- Overview of AI use cases in pharmaceutical R&D
- Regulatory bodies and their AI guidance frameworks
- Key differences: research AI vs. compliance-ready AI
- Role of GxP in AI system validation
- Data integrity principles: ALCOA+ in AI workflows
- Audit expectations for AI models in regulated environments
- Defining 'validated' in machine learning contexts
- Change control implications for AI updates
- Documentation standards for AI lifecycle management
- Quality oversight roles in AI deployment
- Risk-based approach to AI validation
- Integrating AI into existing quality systems
- Establishing AI governance committees
- Defining roles: AI owner, validator, custodian
- Board-level oversight of AI initiatives
- Ethics review for AI in clinical research
- Cross-functional alignment: R&D, QA, IT, Compliance
- Risk ranking AI projects by regulatory impact
- Escalation pathways for model performance drift
- Vendor oversight in AI procurement
- Third-party audit preparedness
- AI policy development for enterprise adoption
- Training and competency tracking for AI teams
- Incident response planning for AI systems
- Data provenance tracking in AI pipelines
- Structured vs. unstructured data in regulated contexts
- Metadata requirements for auditability
- Data anonymization and privacy compliance
- Data lifecycle controls from ingestion to archival
- Versioning raw and processed datasets
- Access control and audit logging for data assets
- Data quality checks in AI workflows
- Handling missing data in compliance-aware ways
- Data reconciliation between systems
- Change management for data schema updates
- Data retention policies aligned with regulations
- Defining model purpose and intended use
- Algorithm selection under regulatory scrutiny
- Training data representativeness assessment
- Model development environment controls
- Version control for code and models
- Reproducibility in machine learning workflows
- Model documentation: from design to deployment
- Pre-specifying performance thresholds
- Handling class imbalance in regulated data
- Bias and fairness assessment in clinical contexts
- Model explainability for non-technical reviewers
- Documentation for external validation teams
- Defining validation scope for AI systems
- Test plan development for model performance
- Prospective vs. retrospective validation
- Establishing acceptance criteria
- Statistical validation of model outputs
- Robustness testing under edge conditions
- Cross-validation strategies in small datasets
- Challenge testing with expert reviewers
- Validation of model update processes
- Re-validation triggers and frequency
- Third-party validation coordination
- Reporting validation results to auditors
- Deployment approval workflows
- Environment segregation: dev, test, prod
- Model deployment documentation
- Monitoring for model drift and degradation
- Alerting mechanisms for performance shifts
- Automated rollback procedures
- Scheduled re-evaluation of live models
- User access and role-based permissions
- Change control for model updates
- Patch management for AI dependencies
- Incident logging and review
- Decommissioning validated models
- Preparing AI documentation packages
- Traceability from requirements to validation
- Common audit findings in AI systems
- Mock audit exercises
- Regulator communication strategies
- Handling document requests efficiently
- Evidence retention for AI lifecycle
- Corrective action plans for audit gaps
- Post-inspection follow-up protocols
- Continuous readiness practices
- Leveraging audit feedback for improvement
- Cross-jurisdictional audit expectations
- Integrating AI into change control workflows
- Assessing regulatory impact of AI changes
- Risk-based change categorization
- Approval routing for AI updates
- Deviation management for AI systems
- Post-implementation review processes
- Training updates for AI changes
- Communication plans for AI deployments
- Documentation updates in change control
- Retrospective change analysis
- Managing emergency changes compliantly
- Audit trail maintenance for changes
- Due diligence for AI vendors
- Contractual requirements for AI services
- Right-to-audit clauses
- Vendor risk classification
- Oversight of cloud-based AI platforms
- Data protection in third-party AI
- Performance monitoring of vendor models
- Incident response coordination with vendors
- Transition planning for vendor changes
- Knowledge transfer requirements
- Compliance validation of vendor deliverables
- Ongoing vendor audit programs
- AI in patient recruitment and site selection
- Predictive analytics for trial enrollment
- Compliance considerations in digital endpoints
- AI for adverse event prediction
- Model validation in clinical decision support
- Regulatory submission of AI-augmented data
- Blinding and unblinding in AI-assisted trials
- Data monitoring committee oversight
- AI use in adaptive trial designs
- Documentation standards for clinical AI
- Post-marketing surveillance with AI
- Translational research with AI models
- AI for molecular design and screening
- Validation of in silico toxicity models
- Data standards in preclinical AI
- Compliance in high-throughput screening
- AI-assisted lead optimization
- Model interpretability in chemistry space
- Reproducibility in computational workflows
- Data sharing across discovery teams
- IP considerations in AI-generated compounds
- Regulatory expectations for AI in IND submissions
- Audit readiness for discovery platforms
- Collaboration with CROs using AI
- Enterprise AI roadmap development
- Centralized vs. decentralized AI models
- AI Center of Excellence design
- Standardized templates and playbooks
- Cross-portfolio AI oversight
- Metrics for AI compliance maturity
- Training programs for AI compliance
- Lessons from industry implementations
- Benchmarking against peers
- Continuous improvement of AI governance
- Preparing for new regulatory guidance
- Sustaining compliance culture at scale
How this maps to your situation
- New AI initiatives stalled by compliance concerns
- Ongoing AI projects lacking formal validation
- Preparation for regulatory inspections
- Scaling AI across multiple R&D units
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 40 hours of self-paced learning, designed for working professionals.
How this compares to the alternatives
Unlike generic AI courses, this program is built specifically for pharmaceutical R&D’s regulatory demands, offering implementation-grade tools rather than conceptual overviews or academic theory.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.